D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

Name of the Condition

• Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

Summary

Severe combined immunodeficiency (SCID) with low or normal B-cell numbers is a rare, life-threatening inherited disorder characterized by profound defects in both cellular and humoral immunity, leading to extreme susceptibility to infections. This condition results from genetic mutations that disrupt the development or function of immune cells, particularly T cells, while B-cell numbers may be low or within normal ranges. The impaired immune response compromises the body's ability to fight off pathogens effectively.

Causes

SCID with low or normal B-cell numbers is caused by genetic mutations affecting genes critical for immune cell development and function. These mutations disrupt signaling pathways, cell maturation, or enzyme activity essential for lymphocyte production. Inheritance is typically autosomal recessive, though specific genetic mechanisms may vary by subtype. The condition arises from errors in DNA that impair the body's ability to generate functional immune cells.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency disorders.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive forms.
• Certain ethnic backgrounds with higher prevalence of specific genetic mutations.

Symptoms

• Recurrent, severe, or persistent infections (e.g., bacterial, viral, fungal).
• Failure to thrive or delayed growth in infants and children.
• Chronic diarrhea or gastrointestinal issues.
• Skin rashes or infections.
• Respiratory infections (e.g., pneumonia, bronchitis).
• Oral thrush or other fungal infections.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory testing, and genetic analysis. Blood tests assess immune cell counts and function, including T-cell and B-cell levels. Functional assays evaluate immune response to infections or vaccines. Genetic testing identifies specific mutations associated with the condition. Newborn screening for SCID may detect the disorder early in some regions.

Treatment Options

Treatment focuses on restoring immune function and managing infections. Hematopoietic stem cell transplantation (HSCT) is the primary curative option, replacing defective immune cells with healthy ones from a donor. Gene therapy may be an option for specific genetic subtypes. Supportive care includes antibiotics, antivirals, or antifungals to treat infections, as well as immunoglobulin replacement therapy if B-cell function is impaired. Isolation and infection prevention measures are critical.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment. Untreated SCID is fatal within the first year of life due to severe infections. With prompt HSCT or gene therapy, survival rates improve significantly, though long-term outcomes vary. Follow-up includes regular monitoring of immune function, infection surveillance, and management of potential complications. Lifelong immunosuppression or other therapies may be necessary.

Complications

• Severe, life-threatening infections (e.g., sepsis, meningitis).
• Graft-versus-host disease (GVHD) after stem cell transplantation.
• Chronic lung disease from recurrent respiratory infections.
• Failure to thrive or developmental delays.
• Increased risk of certain cancers due to impaired immune surveillance.

Lifestyle & Prevention

• Strict infection control measures, such as avoiding crowded places or sick individuals.
• Good hygiene practices, including handwashing and avoiding raw foods.
• Vaccination schedules may need adjustment; live vaccines are typically contraindicated.
• Nutritional support to address growth or feeding issues.
• Genetic counseling for families with a history of immunodeficiency disorders.

When to Seek Professional Help

Seek immediate medical attention if experiencing:

• Fever or signs of infection (e.g., cough, diarrhea, rash).
• Unusual or severe infections that do not improve with treatment.
• Failure to thrive or poor weight gain in infants.
• Recurrent infections requiring frequent medical care.
• Symptoms of sepsis (e.g., rapid breathing, lethargy, low blood pressure).

Tips for Medical Coders

When coding D81.2 (Severe combined immunodeficiency [SCID] with low or normal B-cell numbers), ensure documentation supports the specific B-cell profile (low or normal) and confirms the diagnosis of SCID. Verify that the condition is distinguished from other immunodeficiency subtypes, as coding accuracy relies on precise clinical details. Document any genetic testing or immune function results to support the diagnosis. Avoid coding for unspecified immunodeficiencies; specificity is key for accurate reporting.